Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Dark Chocolate With Added Plant Sterols Reduces Cholesterol and Blood-Pressure Levels
Link ID 5118
Title Dark Chocolate With Added Plant Sterols Reduces Cholesterol and Blood-Pressure Levels
Url http://www.medscape.com/viewarticle/573408?src=rss
Description The benefits of eating a dark chocolate bar, a cocoa-flavanols-rich product supplemented with plant sterols, occurred without any weight gain, suggesting it might be helpful in the dietary management of cardiovascular risk, say investigators. Heartwire
Category Articles > Cardiology
Keywords
Date Apr 24, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Calcium Supplements Increase Vascular Events?
  A study shows that calcium supplementation might increase vascular events in elderly women, which is unexpected, because previous trials have shown that calcium improves blood cholesterol levels. Medscape Medical News
Category:   Articles > Cardiology


2. Erythropoiesis-Stimulating Agents May Not Be Safe for Cancer Patients
  Erythropoietin and darbepoetin, often used to treat chemotherapy-associated anemia, may cause serious complications, such as venous thromboembolism, or even death. Medscape Medical News
Category:   Articles > Cardiology


3. Anticoagulation Therapy, Pulmonary Hypertension, and Connective Tissue Disease
  Should anticoagulation therapy be used in patients with pulmonary hypertension and connective tissue disease?
Medscape Pulmonary Medicine
Category:   Articles > Cardiology


4. ACCURACY: CT Angiography Accurately Diagnoses Coronary Stenosis
  Mirroring the results from the recent CORE 64 study, a new multicenter trial has found CTA using a 64-slice scanner can reliably identify stenosis >50% and >70%. Heartwire
Category:   Articles > Cardiology


5. Dual-Acting Receptor Antagonist Reduces Systolic Blood Pressure: No Safety Signals Raised in Phase 2
  The drug, designed to achieve blockade of the endothelin and angiotensin receptors, reduced ambulatory systolic blood pressure almost 15 mm Hg at the highest dose and was safe and well tolerated in a small study of hypertensive patients, report investigators. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS